New hope for Hard-to-Treat colorectal cancer: first human trial launches
Disease control
Recruiting now
This early-stage study tests a new drug called CBI-1214 in people with advanced colorectal cancer that has not responded to standard treatments. The drug works by helping the body's immune cells attack cancer cells. The main goals are to check safety and find the best dose, while…
Phase: PHASE1 • Sponsor: Cartography Biosciences • Aim: Disease control
Last updated May 15, 2026 11:53 UTC